TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

NKY economic development leaders are bullish on 2025 given a strong deal pipeline and the prospect of capturing foreign ...

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...

Telops Radia Family is designed as an accessible entry point into the world of scientific IR imaging. With cooled and ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $573.06 which represents a slight increase of $13.41 or 2.40% from the prior close of $559.65. The stock opened at $563 ...

Food fortification, the deliberate addition of essential micronutrients to staple foods, has been a cornerstone of public health interventions aimed at ...

Ribometrix, a spinout of UNC-Chapel Hill, has named William Marshall as its new CEO, succeeding former chief executive ...

Researchers isolated a strain of Pseudomonas alcaligenes that can withstand temperatures as high as 44 °C from a hot spring ...

Novo Holdings, the controlling shareholder of Novo Nordisk , hopes to double the size of its recently acquired contract ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.